Our comprehensive service offering includes early stage formulation and analytical development, API capsule and vial filling using Xcelodose® technology, scale-up and stability testing, process validation, technology transfer and associated analytical support services.
Our strength lies in the integrated nature of our services, combining formulation development and analytical services with clinical trial supplies.
PCI provide CMC Consultancy services to generate the optimum development strategy for your product. By involving our experts early in the strategic development of your new product, we can assist in optimizing the process, ensure that regulatory hurdles are minimized and that the most efficient routes to clinic are delivered for potent and non-potent molecules.
We are able to offer formulation development services for a variety of dosage forms including:
- Tablets, capsules and powders
- Gels and creams
- Liquids, solutions, suspensions and emulsions
- Suppositories and pessaries
- Granules for reconstitution
- Drug in capsule/vial